BioMap presents AI-based drug safety assessment system
Read more
Pandaily
pandaily.com

BioMap presents AI-based drug safety assessment system

On November 19, BioMap launched a drug safety assessment system using artificial intelligence. This system combines virtual cell models, toxicity prediction, and non-clinical assessment services.

According to information published by the company via Leiphone, this development is intended to help researchers prioritize candidate molecules and safety concerns before they start spending resources on animal studies.

Key Components and Capabilities of the System

One of the key elements is the xTrimoTox toxicity prediction model, which BioMap created based on a cellular world model. The company is also exploring the possibility of virtual dosing through safety prediction models called 'virtual monkeys' to extend predictions beyond cellular reactions to the level of animal impact. It is emphasized that this approach remains a model and requires experimental verification, and is not an approved substitute for animal testing.

BioMap reports AUROC scores of 0.9637 for drug-induced liver injury and 0.8918 for hERG-related cardiotoxicity on selected benchmarks from the Therapeutics Data Commons. Separately, the company cites a score of 0.9076 in a blind test for liver injury involving 47 drugs. It is important to note that these are discrimination metrics claimed by the company itself, not results from clinical trials, diagnostic accuracy percentages, or proof of drug safety or efficacy for patients.

On the Tox21 test set, it claims an average ROC-AUC of 0.8598 for 645 molecules and 12 toxicity endpoints, which is higher than the 0.8470 achieved by DeepTox. These figures have not been independently reproduced for this article, and the comparison relates to the specified benchmark conditions, not universal superiority in safety assessment.

Integration into Non-Clinical Workflow

The product is designed to support several stages of the non-clinical workflow. Before starting research, BioMap integrates laboratory toxicology data, small animal information, and historical data from larger animals or related molecules to determine species selection, dosage groups, and potential target organ risks. During testing, the system analyzes parameters such as body weight, food consumption, lab measurements, and toxicokinetic data to identify signals requiring further investigation.

Regarding pathology and reporting, the company describes features for whole slide preliminary screening, annotation of suspicious areas, and checking data consistency from various sources, report tables, and submission materials. These features assist researchers and pathologists but do not replace their professional judgment.

BioMap has announced partnerships with over 30 contract research organizations and laboratories that are already beginning to participate in projects with the relevant capabilities. Within the proposed feedback loop, partners' animal studies verify the risks noted by the models, and the resulting experimental data is used to refine subsequent predictions. Thus, the launch pertains to an AI-supported research workflow, not proof of confirmed clinical efficacy or regulatory approval.

Similar stories

AIIMS plans to create a national registry to monitor poisoning cases
Read more
timesofindia.indiatimes.com

AIIMS plans to create a national registry to monitor poisoning cases

AIIMS in New Delhi is developing a plan to create a national system for tracking poisoning cases across the country. The proposed National Poisoning Registry will collect reports of poisoning incidents and ensure digital connectivity between poisoning control centers for prompt data transmission.

Under this proposal, the National Poisons Information Centre (NPIC) must transform from a 24-hour telephone consultation service into a national toxicology hub network. This network will include satellite units that will be digitally linked to the AIIMS center.

Within the proposed system, poisoning cases registered in participating centers can feed into a centralized database. This will allow for tracking emerging trends and enhancing emergency preparedness. The plan also includes establishing a national antidote bank, an analytical testing laboratory, and developing research programs, development, and real-time reporting software with artificial intelligence-based diagnostics.

NPIC, established at AIIMS in 1995, became the first such center in India. It evolved from a telephone service advising emergency physicians on poisonings to a 24-hour toxicology resource accepting calls nationwide. Between 1995 and 2025, it received over 65,000 calls related to household products, pesticides, drug overdoses, and snake bites.

NPIC data demonstrates a wide range of exposures, including chemicals from agricultural and industrial sectors, medicines, plants, household goods, as well as bites and burns. Among all calls related to bites and burns, snake bites constituted the largest proportion in both the 2010–19 and 2020–25 periods.

The proposed expansion aims to shift from handling individual emergencies to forming a broader national picture of poisoning patterns. AIIMS has suggested linking the hub center with peripheral units, as well as integrating analytical testing and a national antidote bank to strengthen response to poisoning-related emergencies.

Furthermore, the proposal includes programs for increasing awareness about poisons and building capacity for children, teachers, parents, and workers, as well as a National Awareness and Information Program and the designation of a special National Poison Awareness Day. As part of the expansion, AIIMS has proposed renaming NPIC to the National Network Center for Toxicology Sciences and Research (NNCTSR).

Popular